26.07.2012
- Swiss drugmaker Roche Holding took $1.7 billion in restructuring charges it said should lead to big savings as it confirmed its outlook on Thursday with first-half sales beating...
25.07.2012
- Swiss drug industry supplier Lonza confirmed its profit guidance on Wednesday and said demand in its key business remained strong despite macroeconomic uncertainties. The Basel...
19.07.2012
- Actelion raised its earnings outlook for 2012 on Thursday as cost cuts helped Europe's biggest biotech company to post a first-half profit despite its most important drug facing...
